Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad

8. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders In Q4 2024: 66

Abbott Laboratories (NYSE:ABT) is a global healthcare company whose shares have seen significant action in 2025. Between late January and early March, the shares had gained 23.6% as the firm benefited from the robust performance of its medical devices unit. The division saw Abbott Laboratories (NYSE:ABT) meet analyst guidance estimates for 2025 profit and helped it weather the impact of currency headwinds. Here is what Cramer said about the firm:

“Now I do wanna point out a stock that we’ve been selling for the Charitable Trust, Abbott Labs. There’s a lawsuit that’s been overturned, we talked about that when Robert Ford was on last time. About a very particular kind of specialized infant baby food. A shocking overturning and I’m getting ready to wanna buy the stock back.”